Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C14H18N2O |
| Molecular Weight | 230.3055 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCC[C@@H]1CC2=CNC3=C2C(O)=CC=C3
InChI
InChIKey=XYRKPZYRLSWABB-LLVKDONJSA-N
InChI=1S/C14H18N2O/c1-16-7-3-4-11(16)8-10-9-15-12-5-2-6-13(17)14(10)12/h2,5-6,9,11,15,17H,3-4,7-8H2,1H3/t11-/m1/s1
| Molecular Formula | C14H18N2O |
| Molecular Weight | 230.3055 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:13:41 GMT 2025
by
admin
on
Mon Mar 31 23:13:41 GMT 2025
|
| Record UNII |
46OU9HLZ35
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-4-HO-MPMI
Created by
admin on Mon Mar 31 23:13:41 GMT 2025 , Edited by admin on Mon Mar 31 23:13:41 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
250672-65-2
Created by
admin on Mon Mar 31 23:13:41 GMT 2025 , Edited by admin on Mon Mar 31 23:13:41 GMT 2025
|
PRIMARY | |||
|
10466404
Created by
admin on Mon Mar 31 23:13:41 GMT 2025 , Edited by admin on Mon Mar 31 23:13:41 GMT 2025
|
PRIMARY | |||
|
DTXSID80440389
Created by
admin on Mon Mar 31 23:13:41 GMT 2025 , Edited by admin on Mon Mar 31 23:13:41 GMT 2025
|
PRIMARY | |||
|
4-HO-MPMI
Created by
admin on Mon Mar 31 23:13:41 GMT 2025 , Edited by admin on Mon Mar 31 23:13:41 GMT 2025
|
PRIMARY | 4-HO-MPMI (also known as 4-Hydroxy-N-methyl-(α,N-trimethylene)tryptamine or lucigenol) is a tryptamine derivative that is a psychedelic drug. It was developed by the team led by David Nichols from Purdue University in the late 1990s. This compound produces hallucinogen-appropriate responding in animal tests with a similar potency to the amphetamine-derived psychedelic DOI, and has two enantiomers, with only the (R)-enantiomer being active. | ||
|
46OU9HLZ35
Created by
admin on Mon Mar 31 23:13:41 GMT 2025 , Edited by admin on Mon Mar 31 23:13:41 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> AGONIST |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
